Skip to main content
Modular Medical, Inc. logo

Modular Medical, Inc. — Investor Relations & Filings

Ticker · MODD ISIN · US60785L2079 US Manufacturing
Filings indexed 571 across all filing types
Latest filing 2020-01-27 Director's Dealing
Country US United States of America
Listing US MODD

About Modular Medical, Inc.

https://www.modularmedical.com/

Modular Medical, Inc. is a development-stage medical device company that designs, develops, and intends to commercialize insulin pump technology for diabetes care. The company's primary product is the MODD1 insulin pump, which is engineered for simplicity, affordability, and ease of use. The device is intended to facilitate a smooth transition for individuals moving from multiple daily injections to pump therapy. Modular Medical aims to make advanced diabetes technology more accessible to a broader community of patients and their healthcare providers by removing the complexities associated with traditional insulin delivery systems.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing
2020-01-27 English
Director's Dealing 2020
Director's Dealing
2020-01-27 English
Director's Dealing 2020
Director's Dealing
2020-01-27 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 31, 2019, reporting the appointment of a new board member, Carmen B. Volkart, including details about her background, roles, and compensation. The key content is about changes in the company's board of directors and senior management. There are no financial statements or detailed financial results presented. The document fits the category of Board/Management Information (MANG) as it announces changes in the company's board and management personnel.
2020-01-06 English
FORM 10-Q
Interim / Quarterly Report Q2 2020
2019-11-14 English
FORM 424B1
Capital/Financing Update Classification · 100% confidence The document is a prospectus filed pursuant to Rule 424(b)(1) related to the offer and sale of common stock by selling shareholders. It includes detailed information about the offering, risk factors, use of proceeds, selling shareholders, plan of distribution, and other disclosures typical of a securities offering prospectus. The presence of terms like 'prospectus,' 'selling shareholders,' 'plan of distribution,' and the detailed description of the offering and related risks clearly indicate this is a capital raising document. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document is not an annual or interim report, audit report, or any other category. Therefore, the correct classification is CAP.
2019-10-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.